Provides a baseline for understanding the scale of the bank's investment and lending activities over time.
The total historical cost of assets or liabilities before any accounting adjustments for fair value, impairment, or amor...
Standard accounting disclosure for financial assets and liabilities.
cumulative_cost_basis| Segment | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '26 |
|---|---|---|---|---|---|---|
| Biopharma | $856.00M | $1.40B | $1.40B | $1.50B | $1.50B | $3.30B |
| Total | — | — | — | — | — | — |